A new solution is transforming cardiac care by leveraging the power of artificial intelligence (AI) in point-of-care ultrasound. This innovation enables a wider range of medical professionals to capture high-quality cardiac images with confidence, ultimately enhancing diagnostic accuracy and improving clinical outcomes. Check out the latest episode of Tomorrow's Cure to learn more.

The podcast episode features Dr. Paul Friedman, cardiologist and chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota, and Davidi Vortman, CEO of UltraSight. Together, Mayo Clinic and UltraSight are at the forefront of developing algorithms to analyse and interpret cardiac ultrasound images. The collaboration seeks to create a comprehensive solution to support diagnostic and treatment decisions using point-of-care ultrasound devices.

This AI-driven technology is designed to overcome existing barriers and expand access to high-quality cardiac imaging and diagnostics. UltraSight's innovation simplifies cardiac sonography by providing real-time guidance on maneuvering the ultrasound probe to capture high-quality images. Now, with the added power of AI, healthcare professionals can analyse those images more effectively.

"Historically, ultrasound has been somewhat difficult for an average person to get," says Dr. Friedman. "So, in many places around the world, if a physician orders an ultrasound of the heart, an echocardiogram, it may take several months to be scheduled."

"It hasn't been used for first-line screening because of those barriers. This is where some of the visionary work of a portable device that uses AI can turn that upside," he adds.

This innovative technology isn't about replacing experts, notes Vortman. "We're not replacing the experts, we are giving them more data from more patients, faster than ever before. So AI is an accelerator for access that gives much better data at the right time," he says.

"It doesn't replace human interpretation and action, but it can provide a common groundwork for consistency," Dr. Friedman adds.

Looking ahead, Vortman envisions a future where diagnostic tools are more accessible and affordable. "This is the future. Diagnostic tools like ultrasound that are low-cost and can be used by a wider variety of healthcare team members are going to be future of healthcare and disease detection," he says.

The collaborative effort between Mayo Clinic and UltraSight holds the potential to democratise cardiac care, offering hope faster and more efficiently. Tune in to the latest episode of Tomorrow's Cure to learn more about this solution.  

Mayo Clinic has a financial interest in the technology referenced in this podcast. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Related Articles